KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Dec 2024 value amounting to $331,000.

  • Rigel Pharmaceuticals' Gains from Investment Securities fell 7.39% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 7.39%. This contributed to the annual value of $331,000 for FY2024, which is 90.30% down from last year.
  • As of FY2024, Rigel Pharmaceuticals' Gains from Investment Securities stood at $331,000, which was down 90.30% from $3.4 million recorded in FY2023.
  • Rigel Pharmaceuticals' Gains from Investment Securities' 5-year high stood at $14.2 million during FY2020, with a 5-year trough of $233,750 in FY2021.
  • Its 3-year average for Gains from Investment Securities is $1.5 million, with a median of $817,911 in 2022.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 98.36% in 2021, then soared by 317.12% in 2023.
  • Over the past 5 years, Rigel Pharmaceuticals' Gains from Investment Securities (Yearly) stood at $14.2 million in 2020, then slumped by 98.36% to $233,750 in 2021, then soared by 249.91% to $817,911 in 2022, then surged by 317.12% to $3.4 million in 2023, then plummeted by 90.30% to $331,000 in 2024.